December 2021

The 10 biggest stories of 2021: Diet warnings, COVID-19 updates, lawsuits & more ()
Looking back at December's 10 most popular stories ()
Best of the Week: FDA approves twice-yearly injection that lowers cholesterol | Cardiologist salaries ()
News Alert: FDA approves inclisiran, a twice-yearly injection that lowers cholesterol ()
FDA approves inclisiran | COVID-19 vaccines & myocarditis/myopericarditis | Looking ahead to 2022 ()
Economics & Policy: Cardiologist salaries | Medical malpractice lawsuits | Medicare spending on cardiology drops ()
Heart Failure: The optimal HFrEF treatment | KCCQ-12 scores & acute HF ()
An industry first for Philips | FDA approves rivaroxaban for treating, preventing blood clots in children ()
Vascular & Endovascular: J&J vaccine linked to blood clot risks | New PCI, CABG guidelines | TEVAR outcomes ()
Cardiologist salaries up 2% as pandemic continues | Edwards gains a new FDA approval | DOACs & AFib ()
Heart Rhythm: Ablation vs. drug therapy for AFib | ‘Surprising’ trends in ICD use among HCM patients ()
Vaccine recommendations changed due to risk of blood clots | Cardiologist says US withheld COVID treatments ()
Best of the Week: A new recall | Medtronic receives FDA warning letter | Long COVID & heart damage ()
News Alert: CDC now recommends other COVID-19 vaccines over Johnson & Johnson’s due to blood clots ()
Interventional & Surgery: Percutaneous thrombolytic device recalled | A potential lawsuit | New ACC/AHA guidelines ()
FDA announces recall of intra-aortic balloon pumps | Surgeon wants to sue after being fired over vaccines ()
News Alert: FDA announces Class I recall of intra-aortic balloon pumps after 1 death, 71 complaints ()
Medtronic receives warning letter from FDA | Treating high blood pressure during pregnancy ()
TAVR: CKD & patient mortality | Prosthetic-patient mismatch ()
Stroke symptoms for men vs. women | Journal names first female editor-in-chief ()
House passes valvular heart disease legislation | Senators to question Biden's FDA pick | HIV & HF ()
Acute Coronary Syndromes: Ultra-processed foods & repeat heart attacks | STEMI mortality ()
Long COVID & heart damage | New expert guidelines on PCI, CABG | Pre-TAVR pulmonary artery dilatation ()
Best of the Week: Cardiologist with Omicron bounces back | Medicare spending on cardiology plummets ()
Imaging & Physiology: COVID-19's impact on the heart | The benefits of IVUS ()
Cardiologists back efforts to limit Medicare cuts | Doc recovers from Omicron infection | $641M in savings ()
New details on how COVID-19 impacts the heart | ‘Surprising’ trends in ICD use among HCM patients ()
Practice Management: Medical malpractice in cardiology | Key issues impacting care for CAD, PAD ()
Opinions mixed on new surprise billing legislation | KCCQ-12 scores & acute HF | TEVAR outcomes ()
Young people with vaccine-related myocarditis recover quickly | AI model predicts survival after cardiac surgery ()
Structural Heart Disease: TMVR with transfemoral access shows promise | Calculating risk for TEER patients ()
Medicare spending on cardiology, interventional cardiology down $906M | Ultra-processed foods & CVD ()
Best of the Week: The new Omicron variant | Interventional device recalled | COVID-19 vaccines & myopericarditis ()
Cardiologist discusses testing positive for Omicron variant | The ‘very low’ risk of myocarditis after vaccination ()
FDA announces Class I recall of interventional device | COVID-19 vaccines & myopericarditis | STEMI mortality ()
News Alert: FDA announces Class I recall of percutaneous thrombolytic device after multiple complaints ()